Patrick Cobb

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma

Jeannine M. Brant, Susan L. Beck, William N. Dudley et al. · European Journal of Oncology Nursing · 2011 · 49 citations

Oncology, Cancer Management, Colorectal Cancer +6

Symptom Trajectories in Posttreatment Cancer Survivors

Jeannine M. Brant, Susan L. Beck, William N. Dudley et al. · Cancer Nursing · 2010 · 47 citations

Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion

Howard A. Burris, Ahmad Awada, John G. Kuhn et al. · Anti-Cancer Drugs · 1994 · 44 citations